Remote work and artificial intelligence: medicine in the era of COVID-19 was discussed in the Republic of Tatarstan

The pandemic has made the healthcare system more flexible and accelerated the adoption of technology. Representatives of the industry and business believe that telemedicine and digitalization will be actively used in treatment

Replace the Minister of HEALTH of the Republic of Tatarstan Vladimir Zhavronkov at the session "Medicine in the conditions of COVID-19" as part of KazanSummit-2021 spoke about the change in the healthcare system amid the pandemic. “She has become more flexible. We have learned to react more quickly to changes. But the system does not change by itself, the whole society changes. it is obvious that in the near future telemedicine will develop at a tremendous pace, the era of gadgets will come, and it will be possible to diagnose and treat at home. Such cataclysms as the CORONAVIRUS accelerate this development,” Zhavoronkov said.

PwC Executive DIRECTOR responsible for the healthcare sector, Vladimir Geraskin, agreed that the pandemic showed the possibilities of using artificial intelligence in medicine. “Artificial intelligence is an exoskeleton when making medical, medical, and managerial decisions in healthcare. The artificial intelligence system today is mainly aimed at supporting medical decisions and analyzing images. This is its main area of ​​use. But we understand that the possibilities are much wider,” Geraskin said.

According to him, artificial intelligence can help in data processing. “Every country and territory is accumulating data. But access to them, their use for analysis is difficult for political, legal, territorial and other reasons. It is necessary to create supranational impersonal data banks. And, of course, we need to digitize the primary link and expand access to high-speed Internet,” Geraskin said.

Albert Gaifullin, CEO of PharmMedPolis RT, believes that the pandemic has had a positive impact on a number of businesses related to the medical field. “Those who were able to adapt quickly received an impetus for development. We were able to respond and launch the production of socially important medical devices. And we prepared a platform for the localization of manufacturers. The pandemic has also spurred a quick decision to move from laboratory research to industrial production of medical probes. Almost all of our products were stimulated by non-standard market situations - the coronavirus,” Gaifullin said.